Aurobindo, Glenmark and Zydus recall products in the US market
All three Indian pharma companies have initiated the recall due to quality concerns.
15 December, 2024•2 min
0
15 December, 2024•2 min
0
More in Business
Business
Colgate’s India playbook is losing its lustre
Low-end offerings and ‘specialist’ brands are putting the squeeze on the toothpaste giant. What doesn’t help is its laggy response to market trends.
You may also like
Business
Dr. Reddy’s wants to be India’s fifth largest drugmaker. What will it take?
The stock market has taken note of the company’s ambitious plans in the domestic market. But the path ahead is far from easy.
Internet
Why quick delivery of medicines will be difficult to scale
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.
Health
Indian pharma exporters protesting against new regulations is not a good look
The rules require exporters of certain drugs to get an NOC from importing countries—a small but much-needed step to restoring India’s credibility in the global pharma market.
